Delivery Order SPE2DB22D1002-SPE2DB24FLHN3

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $11,249.24 and a period of performance through October 19, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $18,023.70 and a period of performance through July 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a completion date of July 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $5,624.62 and is a firm fixed price, delivery order contract with a completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these specialty medication capsules to support military treatment programs and other federal healthcare requirements. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The contract is a firm fixed-price delivery order with a ceiling value of $5,624.62 and has a period of performance through October 16, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a completion date of July 24, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 150 mg TASIGNA capsules, a prescription medication, with a ceiling value of $6,007.90 and a completion date of August 5, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of TASIGNA 150 MG CAPSULE 28S, a prescription medication. The contract is a firm-fixed-price delivery order with a total ceiling value of $5,624.62. It was awarded on August 26, 2024 with a period of performance through September 17, 2024. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,007.90, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a prescription medication. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHN3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp (Corporate Office Division) for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $5,624.62 and a period of performance through September 30, 2024. It is a firm fixed-price contract with no set-aside designation.

Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order represents a specific order placed against that overarching IDC vehicle to procure the TASIGNA medication. The DLA, a defense agency, is the funding agency for this award, which aligns with its role in supplying medical products and pharmaceuticals to the U.S. military and other federal healthcare programs.

Generated 12/9/24, 2:08 PM